Takeda Pharmaceutical reported revenue of $7.65B and net income of $0.71B for the quarter ended Jun 2026, up 0.1% year over year. This income statement covers 36 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Nov2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||||||||||||||||||||||||
| Revenue | 7.67B | 7.93B | 8.37B | 7.52B | 7.26B | 7.76B | 8.00B | 7.72B | 22.25B | 7.11B | 8.15B | 7.76B | 23.65B | 6.93B | 7.92B | 7.65B | 23.95B | 7.11B | 7.78B | 7.65B | ||||||||||||||||
| Cost of RevenueCost of Rev | 2.51B | 2.48B | 2.52B | 2.26B | 2.21B | 2.38B | 2.43B | 2.34B | 7.23B | 2.59B | 2.61B | 2.49B | 8.03B | 2.52B | 2.54B | 2.66B | 8.13B | 2.64B | 2.59B | 2.55B | ||||||||||||||||
| Gross Profit | 5.17B | 5.45B | 5.85B | 5.39B | 15.47B | 4.58B | 5.58B | 5.10B | 15.02B | 4.52B | 5.54B | 5.02B | 15.62B | 4.42B | 5.38B | 5.40B | 15.81B | 4.48B | 5.19B | 5.10B | ||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||
| Amortization - Intangibles | -0.96B | -2.68B | -0.81B | -0.93B | -0.95B | -2.68B | -0.91B | -0.94B | -0.89B | -2.76B | -0.90B | -0.91B | -0.96B | -2.79B | -0.89B | -0.82B | ||||||||||||||||||||
| Research & DevelopmentR&D | -1.20B | -1.13B | -1.24B | -1.11B | -1.12B | -1.24B | -1.23B | -1.19B | -1.27B | -1.27B | -1.32B | -1.08B | -1.18B | -1.12B | -1.42B | -0.99B | -1.10B | -1.14B | -1.25B | -1.05B | ||||||||||||||||
| Selling, General & AdministrativeSG&A | -1.93B | -2.03B | -1.99B | -1.79B | -1.80B | -1.86B | -1.88B | -1.81B | -1.75B | -1.81B | -1.92B | -1.73B | -1.80B | -1.78B | -1.94B | -1.77B | -1.72B | -1.84B | -1.86B | -1.80B | ||||||||||||||||
| Restructuring CostsRestructuring | ||||||||||||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | 0.98B | -2.46B | 1.29B | 1.23B | 1.15B | -2.30B | 1.15B | 1.42B | 1.09B | -2.45B | 0.95B | 1.59B | 0.91B | -2.67B | 1.05B | 1.28B | ||||||||||||||||||||
| Operating ExpensesOpex | -3.12B | -3.16B | -3.23B | -1.92B | -5.38B | -1.80B | -1.88B | -1.85B | -5.32B | -1.93B | -1.82B | -1.72B | -5.42B | -1.95B | -1.77B | -1.85B | -5.49B | -1.92B | -1.83B | -2.85B | ||||||||||||||||
| Operating IncomeOp. Inc | 0.89B | 1.02B | 2.14B | 1.16B | 0.76B | 1.04B | 1.27B | 1.23B | 2.78B | 0.60B | 1.14B | 1.07B | 2.80B | -0.49B | 1.21B | 1.28B | 2.87B | -2.70B | 1.28B | 1.26B | ||||||||||||||||
| EBIT | 0.89B | 1.02B | 2.14B | 1.16B | 0.76B | 1.04B | 1.27B | 1.23B | 2.78B | 0.60B | 1.14B | 1.07B | 2.80B | -0.49B | 1.21B | 1.28B | 2.87B | -2.70B | 1.28B | 1.26B | ||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | -0.36B | -0.41B | -0.20B | -0.43B | -0.39B | -0.56B | -0.45B | -0.43B | -1.20B | -0.33B | -0.40B | -0.38B | -1.16B | -0.33B | -0.70B | -0.74B | -2.13B | -0.35B | -0.68B | -0.40B | ||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.06B | 0.04B | 113.39B | 0.47B | 0.11B | 0.30B | 105.52B | 0.19B | 0.38B | 0.09B | 0.21B | 0.20B | 0.31B | 0.12B | 0.48B | 0.51B | 1.40B | 0.12B | 0.47B | 0.15B | ||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.01B | 0.02B | ||||||||||||||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | ||||||||||||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||
| EBT | 0.56B | 0.64B | 1.92B | 1.20B | 0.47B | 0.76B | 1.18B | 0.99B | 2.27B | 0.32B | 0.92B | 0.88B | 1.89B | -0.71B | 0.99B | 1.04B | 2.12B | -2.96B | 1.04B | 1.02B | ||||||||||||||||
| Tax ProvisionsTaxes | -0.14B | -0.13B | -0.73B | -0.39B | -0.02B | 0.08B | -0.38B | -0.33B | 0.32B | 0.30B | -0.31B | -0.27B | -0.48B | 0.29B | -0.27B | -0.18B | -0.65B | 0.56B | -0.32B | -0.31B | ||||||||||||||||
| Profit After TaxPAT | 0.42B | 0.51B | 1.18B | 0.81B | 0.45B | 0.84B | 0.79B | 0.65B | 1.98B | 0.21B | 0.64B | 0.61B | 1.42B | -0.68B | 0.81B | 0.86B | 1.47B | -2.39B | 0.79B | 0.71B | ||||||||||||||||
| Equity Income | -0.03B | -0.02B | -0.00B | -0.00B | -0.01B | -0.01B | -0.00B | -0.00B | -0.02B | -0.04B | -0.00B | -0.00B | -0.02B | 0.02B | -0.00B | -0.00B | -0.02B | -0.01B | -0.00B | 0.00B | ||||||||||||||||
| Income from Non-Controlling InterestsInc. Minority | 0.00B | 0.00B | -0.00B | 0.00B | -0.00B | 0.00B | 0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | 0.00B | ||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | 0.70B | 0.76B | 2.65B | 1.59B | 0.49B | 0.67B | 1.56B | 1.32B | 1.94B | 0.02B | 1.23B | 1.14B | 2.37B | -1.00B | 1.26B | 1.22B | 2.78B | -3.52B | 1.35B | 1.33B | ||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | 0.70B | 0.76B | 2.65B | 1.59B | 0.49B | 0.67B | 1.56B | 1.32B | 1.94B | 0.02B | 1.23B | 1.14B | 2.37B | -1.00B | 1.26B | 1.22B | 2.78B | -3.52B | 1.35B | 1.33B | ||||||||||||||||
| Income towards Parent CompanyParent Net Inc | 0.42B | 0.51B | -0.10B | 0.81B | 0.45B | 0.84B | 0.79B | 0.65B | 1.98B | 0.21B | 0.64B | 0.61B | 1.42B | -0.68B | 0.81B | 0.86B | 1.47B | -2.39B | 0.79B | 0.71B | ||||||||||||||||
| Net Income towards Common StockholdersNet Income | 0.42B | 1.15B | -0.10B | 0.81B | 0.45B | 0.84B | 0.79B | 0.65B | 1.98B | 0.21B | 0.64B | 0.61B | 1.42B | -0.68B | 0.81B | 0.86B | 1.47B | -2.39B | 0.79B | 0.71B | ||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||
| EPS (Basic) | 2.94 | 8.11 | -0.69 | 5.71 | 3.15 | 5.93 | 5.63 | 4.62 | 14.03 | 1.49 | 4.52 | 4.30 | 9.95 | -4.77 | 5.67 | 5.98 | 10.22 | -16.68 | 5.53 | 4.96 | ||||||||||||||||
| EPS (Diluted) | 2.92 | 8.05 | -0.68 | 5.66 | 3.12 | 5.88 | 5.56 | 4.57 | 13.87 | 1.47 | 4.47 | 4.26 | 9.85 | -4.72 | 5.58 | 5.88 | 10.05 | -16.41 | 5.53 | 4.96 | ||||||||||||||||
| Shares Outstanding | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | ||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | 0.15B | 0.15B | 0.15B | 0.15B | 0.14B | 0.14B | ||||||||||||||||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 0.14B | 0.14B | 0.14B | 0.14B | 0.14B | |||||||||||||||||||||||||||||||
| EBITDA | 0.89B | 1.02B | 2.14B | 1.16B | 0.76B | 1.04B | 1.27B | 1.23B | 2.78B | 0.60B | 1.14B | 1.07B | 2.80B | -0.49B | 1.21B | 1.28B | 2.87B | -2.70B | 1.28B | 1.26B | ||||||||||||||||
| Interest ExpensesInt Expense | -0.36B | -0.41B | -0.20B | -0.43B | -0.39B | -0.56B | -0.45B | -0.43B | -1.20B | -0.33B | -0.40B | -0.38B | -1.16B | -0.33B | -0.70B | -0.74B | -2.13B | -0.35B | -0.68B | -0.40B | ||||||||||||||||
| Tax Rate | -25.15% | -19.91% | -38.25% | -32.45% | -4.36% | 11.20% | -32.48% | -33.79% | 14.33% | 92.90% | -33.38% | -30.24% | -25.18% | -41.47% | -27.42% | -17.49% | -30.83% | -19.03% | -30.42% | -30.40% |